US Patent Issued to Progenika Biopharma, UEA Enterprises on Feb. 4 for "Mitochondrial nucleic acid depletion and detection" (British, Spanish Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,376, issued on Feb. 4, was assigned to Progenika Biopharma S.A. (Derio, Spain) and UEA Enterprises Ltd. (Norwich, Great Britain).

"Mitochondrial nucleic acid depletion and detection" was invented by Lourdes Palacios (Derio, Spain), Nerea Bartolome (Derio, Spain), Antonio Martinez (Derio, Spain), Justin Joseph O'Grady (Norwich, Great Britain) and Gemma Louise Kay (Norwich, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for depleting host nucleic acid in a biological sample, said sample having been previously obtained from an animal host and having been subjected to treatment to lyse host cells pres...